Public health advocates and community activists established early methods for naloxone distribution to people who inject drugs, but a legacy of stigmatization and opposition to universal naloxone access continues to limit the drugs full potential to reduce opioid-related mortality. To view or add a comment, sign in A debate over the adoption of GLP-1 weight-loss drugs in India has intensified after Biocon Executive Chairperson Kiran Mazumdar-Shaw cautioned against their widespread use among healthy individuals, responding to Zerodha Founder and CEO Nithin Kamath's observations on weaker-than-expected demand for generic versions of the medicines
Early trials suggest it could help patients lose up to a quarter of their body weight
While Ozempic is not specifically for weight loss, Ozempic s ingredient, semaglutide, was approved for weight management by the FDA in 2021
The grafts in both the GSH and control groups were remodeled into a fat mass with a vascularized capsule
These risks and uncertainties include, among other things, risks related to the commercialization and market acceptance of the Company's products and services, the Company's ability to successfully expand its pharmacy network and telehealth initiatives, regulatory and compliance considerations relating to medical foods and healthcare products, competition in the healthcare and pharmaceutical distribution markets, changes in market conditions, and other risks and uncertainties described from time to time in the Company's filings with the U.S
